Dovitinib
-
Catalog numberB1614-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_nameDovitinib, CHIR-258; CHIR 258; CHIR258; 1-amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one; (3Z)-4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1,3-dihydrobenzimidazol-2-ylidene]quinolin-2-one; TKI258; TKI-258; TKI 258 ; Multitargeted RTK inhibitor
-
DescriptionDovitinib (TKI258, CHIR258) is a multitargeted RTK inhibitor
-
CAS Number405169-16-6
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₁H₂₁FN₆O
-
Molecular Weight392.43
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (30 mg/mL)
-
HandlingProtect from air and light
-
Tag LineA multitargeted RTK inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD10565680
-
PubChem CID9886808
-
SMILESCN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3
-
InChi1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11,24-25H,7-10,23H2,1H3/b20-18-
-
InChi KeyKCOYQXZDFIIGCY-ZZEZOPTASA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameDovitinib
-
Alternative nameDovitinib
-